USFDA concludes inspection at SMS Pharmaceuticals’ Central Laboratory Analytical Services

25 Jun 2025 Evaluate

United States Food and Drug Administration (USFDA) has concluded inspection at SMS Pharmaceuticals’ Central Laboratory Analytical Services, located at Hyderabad, Telangana. The inspection, conducted from June 23, 2025 to June 25, 2025, concluded with zero Form 483 observations. 

The Company is committed to meeting the highest quality standards and is further committed to full compliance with CGMP & GLP regulations at all its manufacturing & Analytical facilities. The Central Laboratory Analytical Services is company’s independent testing laboratory, and this was the second successful USFDA inspection for the facility.

SMS Pharmaceuticals is a diversified and integrated pharmaceutical company specialising in API and intermediates for global customers.

SMS Pharmaceuticals Share Price

313.10 2.95 (0.95%)
01-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.40
Dr. Reddys Lab 1253.60
Cipla 1500.10
Zydus Lifesciences 914.50
Lupin 2103.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×